MNKD

3.93

2.88% 0.11

Handel nachbörslich: 3.92 -0.01 -0.25%

Mannkind Corp (MNKD)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MNKD? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$3.82

Offen:

$3.83

24-Stunden-Volumen:

2.29M

Relative Volume:

0.94

Marktkapitalisierung:

$1.19B

Einnahmen:

$248.37M

Nettoeinkommen (Verlust:

$11.74M

KGV:

78.60

EPS:

0.05

Netto-Cashflow:

$18.24M

1W Leistung:

+2.08%

1M Leistung:

+4.24%

6M Leistung:

-36.30%

1J Leistung:

-31.53%

1-Tages-Spanne:

$3.825

$3.94

1-Wochen-Bereich:

$3.7378

$4.00

52-Wochen-Spanne:

$3.51

$7.63

Mannkind Corp Stock (MNKD) Company Profile

Firmenname

Mannkind Corp

Sektor

Healthcare (1161)

Branche

Biotechnology (653)

Telefon

818-661-5000

Adresse

1 CASPER STREET, DANBURY, CA

Mitarbeiter

407

Twitter

@MannKindCorp

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

MNKD's Discussions on Twitter

Vergleichen Sie MNKD mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MNKD Mannkind Corp	3.93	1.17B	248.37M	11.74M	18.24M	0.05
VRTX Vertex Pharmaceuticals Inc	470.13	119.21B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	560.93	59.16B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	325.28	40.57B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	571.23	34.02B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	295.59	29.19B	3.81B	-644.79M	-669.77M	-6.24

Mannkind Corp Stock (MNKD) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-16	Fortgesetzt	H.C. Wainwright	Buy
2025-04-10	Eingeleitet	Mizuho	Outperform
2025-02-10	Eingeleitet	Wedbush	Outperform
2024-12-20	Eingeleitet	Wells Fargo	Overweight
2024-12-19	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2024-09-09	Fortgesetzt	Leerink Partners	Outperform
2024-06-13	Eingeleitet	Rodman & Renshaw	Buy
2023-10-10	Eingeleitet	Wedbush	Outperform
2021-05-14	Eingeleitet	RBC Capital Mkts	Sector Perform
2019-12-24	Eingeleitet	Oppenheimer	Outperform
2019-10-25	Eingeleitet	Cantor Fitzgerald	Overweight
2019-05-14	Eingeleitet	BTIG Research	Buy
2019-03-04	Eingeleitet	SVB Leerink	Outperform
2019-02-22	Eingeleitet	SVB Leerink	Outperform
2018-02-28	Herabstufung	Maxim Group	Hold → Sell
2017-11-01	Herabstufung	Maxim Group	Buy → Hold
2017-10-10	Eingeleitet	H.C. Wainwright	Buy
2017-10-06	Bestätigt	Maxim Group	Buy
2017-08-11	Eingeleitet	Maxim Group	Buy
2016-05-10	Bestätigt	Piper Jaffray	Underweight
2016-05-10	Bestätigt	RBC Capital Mkts	Underperform
2016-01-06	Bestätigt	Piper Jaffray	Underweight
2016-01-06	Bestätigt	RBC Capital Mkts	Underperform
2015-11-04	Herabstufung	RBC Capital Mkts	Outperform → Underperform
2015-09-09	Herabstufung	Piper Jaffray	Neutral → Underweight
2015-08-03	Bestätigt	RBC Capital Mkts	Outperform
2015-05-11	Herabstufung	JP Morgan	Neutral → Underweight
2015-05-11	Bestätigt	MLV & Co	Hold
2015-04-16	Bestätigt	RBC Capital Mkts	Outperform

Alle ansehen

Mannkind Corp Aktie (MNKD) Neueste Nachrichten

Jul 22, 2025

11 Best American Penny Stocks to Buy According to Analysts - Insider Monkey

Jul 22, 2025

What analysts say about MannKind Corporation stockLightning-fast capital gains - jammulinksnews.com

Jul 22, 2025

Jul 20, 2025

What drives MannKind Corporation stock priceExtraordinary profit generation - Autocar Professional

Jul 20, 2025

Jul 19, 2025

MannKind Corporation Stock Analysis and ForecastBreakthrough profits - jammulinksnews.com

Jul 19, 2025

MannKind (NASDAQ:MNKD) Upgraded at HC Wainwright - Defense World

Jul 19, 2025

Jul 17, 2025

Mannkind director Binder sells $296945 in shares By Investing.com - Investing.com South Africa

Jul 17, 2025

Jul 16, 2025

H.C. Wainwright assumes coverage on MannKind stock with Buy rating - Investing.com

Jul 16, 2025

Jul 15, 2025

What makes MannKind Corporation stock price move sharplyLow Risk Scalping Alerts - Newser

Jul 15, 2025

How MannKind Corporation stock performs during market volatilityPortfolio Boosting Stock Alerts - Newser

Jul 15, 2025

Why MannKind Corporation stock attracts strong analyst attentionGrowth Stock Monitor - Newser

Jul 15, 2025

Jul 14, 2025

High Growth Tech Stocks To Watch In The US July 2025 - Yahoo Finance

Jul 14, 2025

Jul 11, 2025

Wells Fargo Maintains a Buy Rating on MannKind Corporation (MNKD), Sets a $9 PT - Insider Monkey

Jul 11, 2025

MannKind Corporation(NasdaqGM: MNKD) dropped from Russell 3000 Value Index - MarketScreener

Jun 29, 2025

Jun 27, 2025

Today In SCV History: June 27, 2014 – Valencia Company Given FDA Approval For Inhaled Insulin - KHTS Radio

Jun 27, 2025

Jun 25, 2025

Is Day One Biopharmaceuticals, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025

Jun 24, 2025

Leerink Partners Slashes MannKind Corporation’s (MNKD) Price Target to $7, Keeps a Buy Rating - Insider Monkey

Jun 24, 2025

Jun 23, 2025

13 Best Long-Term Penny Stocks to Buy According to Analysts - Insider Monkey

Jun 23, 2025

Jun 17, 2025

MannKind stock hits 52-week low at $3.70 - Investing.com

Jun 17, 2025

Jun 11, 2025

Top 3 Health Care Stocks That May Rocket Higher This Quarter - Benzinga

Jun 11, 2025

Jun 10, 2025

Insider Sell: Steven Binder Sells 64,085 Shares of MannKind Corp (MNKD) - GuruFocus

Jun 10, 2025

MannKind director Steven Binder sells $256,340 in shares By Investing.com - Investing.com South Africa

Jun 10, 2025

MannKind director Steven Binder sells $256,340 in shares - Investing.com Australia

Jun 10, 2025

Phase II home run: Insmed’s TPIP hits hypertension endpoints - BioWorld MedTech

Jun 10, 2025

MannKind stock touches 52-week low at $4.04 amid market shifts - Investing.com Nigeria

Jun 10, 2025

Jun 09, 2025

MannKind to present inhaled insulin study at ADA event By Investing.com - Investing.com Canada

Jun 09, 2025

MannKind to present inhaled insulin study at ADA event - Investing.com

Jun 09, 2025

Breakthrough in Pediatric Diabetes Care: MannKind Phase 3 Trial Data Reveals New Inhaled Insulin Treatment Option - Stock Titan

Jun 09, 2025

Jun 05, 2025

MannKind at Jefferies Global Healthcare: Strategic Growth and Innovation By Investing.com - Investing.com Canada

Jun 05, 2025

MannKind at Jefferies Global Healthcare: Strategic Growth and Innovation - Investing.com Australia

Jun 05, 2025

MannKind To Present At Jefferies Global Healthcare Conference; Webcast At 2:35 PM ET - Nasdaq

Jun 05, 2025

May 28, 2025

Editas Medicine, Cassava Sciences among healthcare stocks to join Russell Microcap; MNKD, OCGN to exit - Seeking Alpha

May 28, 2025

May 27, 2025

MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition - Seeking Alpha

May 27, 2025

May 23, 2025